Last update:

Weight management news

One molecule, two effects: A new drug concept to treat obesity and type 2 diabetes

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...

What to know about GLP-1 drugs for weight loss and health

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact this has had on health ...

Obesity decreases lung function in older adults

In a new study, researchers found that older adults with obesity had significantly decreased measures of lung function compared to those without obesity, and the results were consistent among men and women. These results ...

Semaglutide improves vascular responsiveness to insulin

Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and substantially lower the risk of heart attacks, strokes, and death from heart disease. A new study conducted ...

Diet tips during cancer treatment

Cancer treatments can take a toll on a person's body. A patient's treatment may cause nausea, changes in appetite, taste and smell, diarrhea, or constipation, making it harder to meet their nutritional needs. Fortunately, ...

Fructose emerges as a key driver of metabolic disease

A new report, published in Nature Metabolism, is shedding light on the distinct and underappreciated role of fructose in driving disease, separate from its role as a simple source of calories.

Weight loss leads to notable muscle loss, study finds

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with ...